Highlights and Quick Summary
- Trade and Non-Trade Receivables Growth for the quarter ending March 31, 2023 was 8.74 (a -4.34% decrease compared to previous quarter)
- Year-over-year quarterly Trade and Non-Trade Receivables Growth increased by 8.01%
- Annual Trade and Non-Trade Receivables Growth for 2022 was 9.14 (a -8.64% decrease from previous year)
- Annual Trade and Non-Trade Receivables Growth for 2021 was 10.0 (a -1199.99% decrease from previous year)
Visit stockrow.com/DSGN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Trade and Non-Trade Receivables Growth of Design Therapeutics, Inc.
Most recent Trade and Non-Trade Receivables Growthof DSGN including historical data for past 10 years.Interactive Chart of Trade and Non-Trade Receivables Growth of Design Therapeutics, Inc.
Design Therapeutics, Inc. Trade and Non-Trade Receivables Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 8.74 | – | – | – | – |
| 2022 | 9.14 | 14.87 | 8.09 | 2.7 | 9.14 |
| 2021 | – | – | – | – | 10.0 |
| 2020 | – | – | – | – | -0.91 |
Business Profile of Design Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology